GEVO INC (GEVO)

US3743964062 - Common Stock

0.7124  +0.07 (+10.04%)

After market: 0.6929 -0.02 (-2.74%)

Fundamental Rating

2

We assign a fundamental rating of 2 out of 10 to GEVO. GEVO was compared to 214 industry peers in the Oil, Gas & Consumable Fuels industry. GEVO scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. GEVO is valied quite expensively at the moment, while it does show a decent growth rate.



0

1. Profitability

1.1 Basic Checks

GEVO had negative earnings in the past year.
In the past year GEVO has reported a negative cash flow from operations.
In the past 5 years GEVO always reported negative net income.
In the past 5 years GEVO always reported negative operating cash flow.

1.2 Ratios

Looking at the Return On Assets, with a value of -10.18%, GEVO is doing worse than 91.59% of the companies in the same industry.
The Return On Equity of GEVO (-11.88%) is worse than 85.98% of its industry peers.
Industry RankSector Rank
ROA -10.18%
ROE -11.88%
ROIC N/A
ROA(3y)-11.11%
ROA(5y)-18.09%
ROE(3y)-12.96%
ROE(5y)-21.17%
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

With a Gross Margin value of 6.80%, GEVO is not doing good in the industry: 79.91% of the companies in the same industry are doing better.
GEVO does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 6.8%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A

4

2. Health

2.1 Basic Checks

GEVO does not have a ROIC to compare to the WACC, probably because it is not profitable.
GEVO has more shares outstanding than it did 1 year ago.
Compared to 5 years ago, GEVO has more shares outstanding
GEVO has a worse debt/assets ratio than last year.

2.2 Solvency

Based on the Altman-Z score of -0.39, we must say that GEVO is in the distress zone and has some risk of bankruptcy.
GEVO has a Altman-Z score of -0.39. This is in the lower half of the industry: GEVO underperforms 74.77% of its industry peers.
A Debt/Equity ratio of 0.00 indicates that GEVO is not too dependend on debt financing.
With an excellent Debt to Equity ratio value of 0.00, GEVO belongs to the best of the industry, outperforming 83.18% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z -0.39
ROIC/WACCN/A
WACC6.85%

2.3 Liquidity

A Current Ratio of 4.23 indicates that GEVO has no problem at all paying its short term obligations.
Looking at the Current ratio, with a value of 4.23, GEVO belongs to the top of the industry, outperforming 86.45% of the companies in the same industry.
A Quick Ratio of 4.18 indicates that GEVO has no problem at all paying its short term obligations.
With an excellent Quick ratio value of 4.18, GEVO belongs to the best of the industry, outperforming 87.38% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 4.23
Quick Ratio 4.18

5

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 36.36% over the past year.
Looking at the last year, GEVO shows a very strong growth in Revenue. The Revenue has grown by 1357.80%.
Measured over the past years, GEVO shows a very negative growth in Revenue. The Revenue has been decreasing by -12.14% on average per year.
EPS 1Y (TTM)36.36%
EPS 3YN/A
EPS 5YN/A
EPS growth Q2Q27.27%
Revenue 1Y (TTM)1357.8%
Revenue growth 3Y45.88%
Revenue growth 5Y-12.14%
Revenue growth Q2Q695.27%

3.2 Future

The Earnings Per Share is expected to grow by 47.84% on average over the next years. This is a very strong growth
The Revenue is expected to grow by 65.73% on average over the next years. This is a very strong growth
EPS Next Y-9.29%
EPS Next 2Y-19.04%
EPS Next 3Y8.69%
EPS Next 5Y47.84%
Revenue Next Year14.98%
Revenue Next 2Y24.94%
Revenue Next 3Y103.27%
Revenue Next 5Y65.73%

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.

0

4. Valuation

4.1 Price/Earnings Ratio

GEVO reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for GEVO. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-19.04%
EPS Next 3Y8.69%

0

5. Dividend

5.1 Amount

GEVO does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

GEVO INC

NASDAQ:GEVO (4/29/2024, 3:44:46 PM)

After market: 0.6929 -0.02 (-2.74%)

0.7124

+0.07 (+10.04%)

Chartmill FA Rating
GICS SectorEnergy
GICS IndustryGroupEnergy
GICS IndustryOil, Gas & Consumable Fuels
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap172.24M
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -10.18%
ROE -11.88%
ROCE
ROIC
ROICexc
ROICexgc
OM N/A
PM (TTM) N/A
GM 6.8%
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.03
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 4.23
Quick Ratio 4.18
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
Growth
EPS 1Y (TTM)36.36%
EPS 3YN/A
EPS 5Y
EPS growth Q2Q
EPS Next Y-9.29%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)1357.8%
Revenue growth 3Y45.88%
Revenue growth 5Y
Revenue growth Q2Q
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y